Portfolio concentration
As of March 31, 2026 · N-PORT
Holdings
105
Top-10 weight
44.42%
Effective holdings
?
The number of equal-weight positions that would produce this portfolio's concentration (1 ÷ Herfindahl index). A 500-stock fund dominated by a few mega-caps might have only ~100 effective holdings.
26
Crowding
?
The value-weighted average number of funds that also own this fund's positions. High = consensus/crowded picks; low = holdings few other funds own.
1020.4
Holdings
As of March 31, 2026 · N-PORT| # | Security | Ticker | Shares | Value | % of fund |
|---|---|---|---|---|---|
| 1 | LILLY ELI and CO | — | 3,189 | $2.93M | 14.48% |
| 2 | UNITEDHEALTH GRP | — | 4,898 | $1.33M | 6.54% |
| 3 | THERMO FISHER SCIENTIFIC INC | — | 1,893 | $930.47K | 4.59% |
| 4 | GILEAD SCIENCES INC | — | 6,020 | $839.01K | 4.14% |
| 5 | ABBOTT LABS | — | 7,720 | $792.61K | 3.91% |
| 6 | DANAHER CORP | — | 2,918 | $553.25K | 2.73% |
| 7 | MEDTRONIC PLC | — | 5,245 | $454.48K | 2.24% |
| 8 | ALNYLAM PHARMACEUTICALS INC | — | 1,262 | $417.56K | 2.06% |
| 9 | STRYKER CORP | — | 1,235 | $405.81K | 2.00% |
| 10 | DYNE THERAPEUTICS INC | — | 20,969 | $380.17K | 1.88% |
| 11 | WATERS CORP | — | 1,192 | $354.98K | 1.75% |
| 12 | BECTON DICKINSON and CO | — | 2,202 | $346.22K | 1.71% |
| 13 | AGILENT TECHNOLOGIES INC | — | 2,996 | $341.48K | 1.69% |
| 14 | ELANCO ANIMAL HEALTH INC | — | 13,428 | $321.33K | 1.59% |
| 15 | HUMANA INC | — | 1,835 | $318.17K | 1.57% |
| 16 | CYTOKINETICS INC | — | 4,722 | $311.23K | 1.54% |
| 17 | WEST PHARMACEUTICAL SVCS INC | — | 1,198 | $300.27K | 1.48% |
| 18 | BOSTON SCIENTIFIC CORP | — | 4,745 | $297.75K | 1.47% |
| 19 | Ascendis Pharma A/S | — | 1,235 | $282.48K | 1.39% |
| 20 | BIOGEN INC | — | 1,390 | $254.83K | 1.26% |
| 21 | VAXCYTE INC | — | 4,136 | $240.34K | 1.19% |
| 22 | IMMUNOME INC | — | 10,669 | $233.33K | 1.15% |
| 23 | METTLER-TOLEDO INTL INC | — | 178 | $224.49K | 1.11% |
| 24 | CENCORA INC | — | 685 | $215.19K | 1.06% |
| 25 | APELLIS PHARMACEUTICALS INC | — | 5,162 | $207.67K | 1.03% |
| 26 | REGENERON PHARMACEUTICALS INC | — | 267 | $206.29K | 1.02% |
| 27 | DEXCOM INC | — | 3,251 | $204.16K | 1.01% |
| 28 | CVS HEALTH CORP | — | 2,698 | $193.77K | 0.96% |
| 29 | MOONLAKE IMMUNOTHERAPEUTICS | — | 9,719 | $181.16K | 0.89% |
| 30 | INSULET CORP | — | 803 | $168.50K | 0.83% |
| 31 | ADAPTIVE BIOTECHNOLOGIES CORP | — | 12,084 | $167.73K | 0.83% |
| 32 | BICARA THERAPEUTICS INC | — | 8,310 | $165.29K | 0.82% |
| 33 | BIONTECH SE ADR | — | 1,829 | $162.56K | 0.80% |
| 34 | IMMATICS NV COMMON STOCK | IMTX US | 16,368 | $161.06K | 0.79% |
| 35 | REPLIGEN CORP | — | 1,359 | $160.12K | 0.79% |
| 36 | COOPER COS INC | — | 2,197 | $157.09K | 0.78% |
| 37 | SHATTUCK LABS INC | — | 24,111 | $155.03K | 0.77% |
| 38 | IDEXX LABS INC | — | 266 | $149.46K | 0.74% |
| 39 | XENON PHARMACEUTICALS INC | — | 2,558 | $148.75K | 0.73% |
| 40 | SAREPTA THERAPEUTICS INC | — | 6,817 | $148.34K | 0.73% |
| 41 | BRISTOL-MYERS SQUIBB CO | — | 2,432 | $147.50K | 0.73% |
| 42 | MOLINA HEALTHCARE INC | — | 1,082 | $144.23K | 0.71% |
| 43 | APOGEE THERAPEUTICS INC | — | 1,658 | $139.55K | 0.69% |
| 44 | CG ONCOLOGY INC | — | 2,028 | $137.26K | 0.68% |
| 45 | AGIOS PHARMACEUTICALS INC | — | 3,906 | $132.14K | 0.65% |
| 46 | INCYTE CORP | — | 1,398 | $131.58K | 0.65% |
| 47 | KYMERA THERAPEUTICS INC | — | 1,497 | $124.69K | 0.62% |
| 48 | OPTION | NVO US | 3,200 | $117.60K | 0.58% |
| 49 | CABALETTA BIO INC | — | 43,630 | $117.36K | 0.58% |
| 50 | ALIGN TECHNOLOGY INC | — | 634 | $108.69K | 0.54% |
1 / 3
Next ›
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.